Literature DB >> 17466040

p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China.

L Yan1, W Na, K Shan, M Xiao-Wei, G Wei, C Shu-Cheng.   

Abstract

p16 is an important tumor suppressor gene, which is inactivated in many kinds of tumors. The common variants of p16 may be associated with the risk of certain tumors development. We analyzed the frequency of two adjacent polymorphisms in p16 exon 3 (540C-->G and 580C-->T) and their haplotype in blood samples from epithelial ovarian cancer (EOC) patients and healthy controls using polymerase chain reaction-restriction fragment length polymorphism. The results showed that the genotype frequency of p16 580C-->T polymorphism was significantly different among histologic subtypes of EOC (P= 0.02). T allele carriers significantly reduced the risk of serous EOC; the adjusted odds ratio was 0.40 (95% CI = 0.19-0.84). There are neither association between p16 540C-->G polymorphism and EOC development, progression, nor association between the haplotypes of two single nucleotide polymorphisms and the tumor development. Our results suggested that the p16 580C-->T polymorphism might affect the individual susceptibility to specific subtypes of EOC. Different types of ovarian cancer might adopt distinct carcinogenetic pathways. However, this result may be further validated in a larger sample of patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466040     DOI: 10.1111/j.1525-1438.2007.00953.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

1.  Association analysis of p16 (CDKN2A) and RB1 polymorphisms with susceptibility to cervical cancer in Indian population.

Authors:  Nisha Thakur; Showket Hussain; Vilas Nasare; Bhudev C Das; Seemi Farhat Basir; Mausumi Bharadwaj
Journal:  Mol Biol Rep       Date:  2011-05-13       Impact factor: 2.316

2.  Frequency of genetic and epigenetic alterations of p14ARF and p16INK4A in head and neck cancer in a Hungarian population.

Authors:  Andrea Kis; Tímea Zsófia Tatár; Tamás Gáll; Róbert Boda; Ildikó Tar; Tamás Major; Pál Redl; Lajos Gergely; Krisztina Szarka
Journal:  Pathol Oncol Res       Date:  2014-04-09       Impact factor: 3.201

3.  Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells.

Authors:  Liu Meimei; Li Peiling; Li Baoxin; Li Changmin; Zhuang Rujin; Hu Chunjie
Journal:  Med Oncol       Date:  2010-01-07       Impact factor: 3.064

4.  Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.

Authors:  Michael S Cunnington; Mauro Santibanez Koref; Bongani M Mayosi; John Burn; Bernard Keavney
Journal:  PLoS Genet       Date:  2010-04-08       Impact factor: 5.917

Review 5.  Role of genetic polymorphisms and ovarian cancer susceptibility.

Authors:  Peter A Fasching; Simon Gayther; Leigh Pearce; Joellen M Schildkraut; Ellen Goode; Falk Thiel; Georgia Chenevix-Trench; Jenny Chang-Claude; Shan Wang-Gohrke; Susan Ramus; Paul Pharoah; Andrew Berchuck
Journal:  Mol Oncol       Date:  2009-02-04       Impact factor: 6.603

6.  Association of SNPs in CDKN2A (P14ARF) Tumour Suppressor Gene With Endometrial Cancer in Postmenopausal Women.

Authors:  Wioletta Wujcicka; Agnieszka Zajac; Krzysztof Szyllo; Beata Smolarz; Hanna Romanowicz; Grzegorz Stachowiak
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

7.  Association between p16(CDKN2A) C540G polymorphism and tumor behavior in prolactinoma: A single-center study.

Authors:  Soner Cander; Mutlu Karkucak; Ozen Oz Gul; Sebnem Ozemri Sag; Tahsin Yakut; Canan Ersoy; Ercan Tuncel; Erdinc Erturk
Journal:  Biomed Rep       Date:  2014-05-19

8.  Two gene polymorphisms (rs4977756 and rs11515) in CDKN2A/B and glioma risk in South Indian population.

Authors:  M K Sibin; I Bhat Dhananjaya; K V L Narasingarao; S M Harshitha; M Jeru-Manoj; G K Chetan
Journal:  Meta Gene       Date:  2016-07-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.